These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Pharmacotherapy for obesity--promise and uncertainty. Yanovski SZ N Engl J Med; 2005 Nov; 353(20):2187-9. PubMed ID: 16291989 [No Abstract] [Full Text] [Related]
50. New diet drug stirs high hopes. But can the pill, rimonabant, liver up to large expectations? Heart Advis; 2005 Feb; 8(2):3. PubMed ID: 15806687 [No Abstract] [Full Text] [Related]
51. Rimonabant in obese patients with type 2 diabetes. Roberfroid D Lancet; 2007 Feb; 369(9561):553; author reply 554-5. PubMed ID: 17307092 [No Abstract] [Full Text] [Related]
52. [New drugs; rimonabant]. van Bronswijk H; Dubois EA; Pijl H; Cohen AF Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2620-2. PubMed ID: 18161263 [TBL] [Abstract][Full Text] [Related]
53. [Pharmacotherapy in the treatment of obesity]. Hamann A MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392 [TBL] [Abstract][Full Text] [Related]
54. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Poirier B; Bidouard JP; Cadrouvele C; Marniquet X; Staels B; O'Connor SE; Janiak P; Herbert JM Diabetes Obes Metab; 2005 Jan; 7(1):65-72. PubMed ID: 15642077 [TBL] [Abstract][Full Text] [Related]
55. Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus. Hollander P Am J Med; 2007 Feb; 120(2 Suppl 1):S18-28; discussion S29-32. PubMed ID: 17296341 [TBL] [Abstract][Full Text] [Related]
56. Panel advises against rimonabant approval. Traynor K Am J Health Syst Pharm; 2007 Jul; 64(14):1460-1. PubMed ID: 17617490 [No Abstract] [Full Text] [Related]
57. Cost-utility analysis of rimonabant in the treatment of obesity. Hampp C; Hartzema AG; Kauf TL Value Health; 2008; 11(3):389-99. PubMed ID: 18179661 [TBL] [Abstract][Full Text] [Related]
58. Rimonabant: endocannabinoid inhibition for the metabolic syndrome. Wierzbicki AS Int J Clin Pract; 2006 Dec; 60(12):1697-706. PubMed ID: 17109677 [TBL] [Abstract][Full Text] [Related]
59. Effect of rimonabant on weight reduction and cardiovascular risk. Astrup A Lancet; 2005 Jul 30-Aug 5; 366(9483):368; author reply 369-70. PubMed ID: 16054932 [No Abstract] [Full Text] [Related]
60. Rimonabant improves weight and glycaemic control: first oral antidiabetic therapy in newly diagnosed type 2 diabetics. Cardiovasc J Afr; 2008; 19(5):282-3. PubMed ID: 18997994 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]